Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw

N/ACompletedNCT01846195

Zynex Monitoring Solutions50 enrolled

Overview

Non-invasive monitoring to measure changes in blood volume.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Blood Loss

Interventions

CM 1500DEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy volunteers * Between 18-35 years of age * Weight between 130-200 pounds Exclusion Criteria: * Known cardiac disease * Recent caffeine intake * Tobacco use in the (4) hours prior to screening * Infection * Pregnancy * Hemoglobin \<13.5 g/dl

Locations (1)

Premier Research Group

Salt Lake City, Utah, United States

Outcomes

Primary Outcomes

Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw

Detection by non-invasive monitoring a change in blood volume (yes or no) during a whole blood draw

Time frame: At study completion (completion of blood draw)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.